Viewing Study NCT04493632

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:27 PM
Ignite Modification Date: 2026-02-20 @ 4:22 PM
Study NCT ID: NCT04493632
Status: RECRUITING
Last Update Posted: 2024-04-30
First Post: 2020-07-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.
Sponsor: OncoSil Medical Limited
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Neoplasm View
None Digestive System Neoplasm View
None Neoplasms by Site View
None Neoplasms View
None Endocrine Gland Neoplasm View
None Digestive System Disease View
None Pancreatic Diseases View
None Endocrine System Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pancreatic Cancer View
None Pancreas View
None Metastases View
None Pancreatic tumor View
None Unresectable View
None Locally advanced View
None Implantable View
None Radiographic View
None Device View
None Phosphorous-32 View
None OncoSil™ View
None Brachytherapy View
None Gemcitabine View
None Nab-paclitaxel View
None Abraxane View